0
play

!"#$%&'()*+$,*-&$).&/#+""0")*-& - PowerPoint PPT Presentation

!"#$%&'()*+$,*-&$).&/#+""0")*-& 12034(&5$0$)(& 6$+*)"+&& 78&'29"&:)*"+)$;()$%&& & & !"#$%&"'()*+,"-.)./," 8(<3,-&


  1. !"#$%&'()*+$,*-&$).&/#+""0")*-& 12034(&5$0$)(& 6$+*)"+&& 78&'29"&:)*"+)$;()$%&& & & !"#$%&"'()*+,"-.)./,"

  2. 8(<3,-& 0"1/2,34,3.5/6"."2,)4./7" 0"8,99.:,3.5,/"2,/;3.2;<"./=".63>>)>/;<" 0"?*2>/<*/6"@63>>)>/;" 0"A>7";>3)<" " " " " " !"#$%&"'()*+,"-.)./,"

  3. :))(=$;()& >$)$#"0")*& 8",?)(%(#@& :6&& '(00"+,3$%3B$;()& :)*"%%",*2$%&6+(<"+*@&& A2-3)"--& !"#$%&"'()*+,"-.)./,"

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

  5. !"#$%&:--2"-&&& M"%$*".&*(&$&G*$+*Y2<&'(0<$)@& • @3529>",B"1/2,34,3.5,/" • C(<*/><<"D.)>"E>6*<;3.5,/"F,3)" • G,).*/"D.)>"8>35H2.;>" • C(<*/><<"?*2>/<>"./="I>3)*;" • J)49,7)>/;"@63>>)>/;" • I.3;/>3<K*4"@63>>)>/;" • I3,;>25,/",B"1I"L4.;>/;<M2,473*6K;MNOM1/=(<;3*.9"G><*6/M I9./;"P.3*>;7Q" • 8,99.:,3.5,/"@63>>)>/;<"L>R6R"ESG"8,99.:,3.5,/" 8,/;3.2;<T"?*2>/<*/6"@63>>)>/;"">;2RQ" • N>2K/*2.9"3>6(9.5,/<"./="<;./=.3=<" • J/B,32>)>/;MG*<4(;>"<>U9>)>/;" !"#$%&"'()*+,"-.)./,"

  6. IP Commercialization " • Sales of IP (Acquisition) • Licensing • Start-up and Spin-off 6/87[8& 87'5[\!\_1&G/!7G& MZJ& '\>>7M':/!:]/8:\[& &/66!:'/8:\[& !:'7[G:[_& G8/M8Y`6G& 'M7/8:\[& 6M\87'8:\[& 7^6!\:8/8:\[& !"#$%&"'()*+,"-.)./,"

  7. !"#$%%@&9(2).&'()*+$,*-&$).& /#+""0")*-&&C(+&& MZJ&'(%%$9(+$;()&$).&8",?)(%(#@&& '(00"+,3$%3B$;()& & • 8,/;3.2;"3><>.32K".63>>)>/;" • 8,99.:,3.5V>"3><>.32K".63>>)>/;" • 8,/<(95/6M+/,W"K,W"@63>>)>/;" • O.;>3*.9";3./<B>3".63>>)>/;"LON@Q" • 8,/H=>/5.9*;7".63>>)>/;"LDG@Q" • I.352*4.5,/".63>>)>/;" • ?*2>/<*/6".63>>)>/;" !"#$%&"'()*+,"-.)./,"

  8. [()&J3-,%(-2+"&/#+""0")*&T[J/U& • @9<,"2.99>=".<" “ 2,/H=>/5.9*;7".63>>)>/; ” " • @/7"*/B,3).5,/"=*<29,<>=";,"./,;K>3"4.3;7" • DG@<"43>V>/;";K*3="4.35><"B3,)"(<*/6";K>"*/B,3).5,/" =*<29,<>="W*;K,(;";K>"4>3)*<<*,/" • DG@<".3>",X>/">Y2K./6>=":>B,3>"9*2>/<*/6"/>6,5.5,/" • 8,)4./*><",X>/"3>Z(><;"3><>.32K>3<";,"<*6/"DG@<":>B,3>" >/;>3*/6"3><>.32K"2,/;3.2;<" !"#$%&"'()*+,"-.)./,"

  9. [()&J3-,%(-2+"&/#+""0")*&T[J/U& DG@"43,V*<*,/<"*/29(=>[" " • 1=>/5H2.5,/",B"4.35><" • 1=>/5H2.5,/",B"2,/H=>/5.9"*/B,3).5,/" • G>H/*5,/",B"4(34,<><"B,3"WK*2K"*/B,3).5,/"2./":>"(<>=" • JR6RT"<,9>97"B,3"4(34,<><",B">V.9(.5/6"."9*2>/<*/6" ,44,3;(/*;7" • E>Z(*3>)>/;<"B,3"3>;(3/M=><;3(25,/",B"2,/H=>/5.9" */B,3).5,/" " !"#$%&"'()*+,"-.)./,"

  10. [()&J3-,%(-2+"&/#+""0")*&T[J/U& DG@"=,><"/,;".4497";,[" " • 1/B,3).5,/"*/";K>"4(:9*2"=,).*/" • 1/B,3).5,/".93>.=7"4,<<><<>=":7";K>"3>2*4*>/;" • 1/B,3).5,/"=*<29,<>=";,";K>"3>2*4*>/;";K3,(6K" 9>6*5).;>")>./<" !"#$%&"'()*+,"-.)./,"

  11. >$*"+3$%&8+$)-C"+&/#+""0")*&T>8/U& • Contracts that govern the transfer of physical assets, • Typically biological materials (reagents, cell lines, plasmids, and vectors) that are transferred for the purpose of research or commercialization • Chemical compounds • MTA ensure transfer of possession but not legal title !"#$%&"'()*+,"-.)./,"

  12. [(&M"="+-"&")#3)""+3)#&'%$2-"& • Prohibits the recipient of confidential information/material from using the information to develop a similar product. • The clause is often included in a NDA/MTA/License Agreement • Commonly used when the disclosed information is source code, product designs or other designs. “No Reverse Engineering: Recipient shall not analyze, decompile, or reverse engineer or cause a third party to analyze, decompile or reverse engineer any Confidential Information for any purpose”. !"#$%&"'()*+,"-.)./,"

  13. IP Licensing " " \ @"3,(;>",B"2,))>32*.9*].5,/"WK>3>"./"1I"3*6K;<"K,9=>3"6*V><" ./,;K>3">/5;7";K>".(;K,3*;7";,">Y49,*;T").+>T"K.V>").=>T"(<>T" <>99T"2,47T"=*<49.7T"=*<;3*:(;>T"),=*B7T">;2R";K>"1I"0"*/"3>;(3/T" ;K>"9*2>/<>>"W*99"4.7"3,7.95><" " \ NK>"),<;"4,4(9.3"./="<(<;.*/.:9>"W.7",B"2,))>32*.9*]*/6"1IE" " \ ^K.3*/6":(<*/><<"3*<+<" \ O./.6>=";K3,(6K"W3*U>/"9>6.997":,(/=".63>>)>/;<" " \ @63>>)>/;<"<54(9.;>"=>;.*9<",B">Y;>/;",B"3*6K;<",B">Y49,*;.5,/" !"#$%&"'()*+,"-.)./,"

  14. !3,")-3)#&/#+""0")*& • G>H/><";K.;"WK.;"9*2>/<,3"./="9*2>/<>>".63>>=";,"9*2>/<>"" • G>H/><"WK.;"7,(".99,W";K>"9*2>/<>>";,"=,"W*;K"*;"./=" WK.;"9>6.9"3*6K;<":,;K"4.35><"K.V>" • F*/./2*.9"./="4.7)>/;"2,/=*5,/<" • ?*2>/<*/6"8,/=*5,/<"" • NK>"9*2>/<,3 ’ <",:9*6.5,/<" • _:9*6.5,/<"2,)),/";,":,;K"4.35><" !"#$%&"'()*+,"-.)./,"

  15. Key Terms and Conditions G29a",*&0$b"+&& • G,(<"&(C&*?"&%3,")-"& • R3"%.&(C&2-"&& • \D)"+-?3<& • '()c.");$%3*@& • 7d,%2-3="&(+&)()Y"d,%2-3="& • G29Y%3,")-3)#& • 8"++3*(+@&& • J2+$;()&R3)$),3$%&*"+0-&& • J"="%(<0")*&+3#?*-& • J"+3=$;="&D(+4-E&30<+(="0")*-& • R2*2+"&="+-3()&(C&*?"&*",?)(%(#@& • e$++$);"-&& • J3-<2*"&-"b%"0")*& • !"#$%&"'()*+,"-.)./,"

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend